DUBLIN (AP) 鈥� DUBLIN (AP) 鈥� Jazz Pharmaceuticals PLC (JAZZ) on Monday reported second-quarter net income of $192.8 million.
The Dublin-based company said it had profit of $2.78 per share. Earnings, adjusted for one-time gains and costs, were $5.71 per share.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $6.04 per share.
The drugmaker posted revenue of $1.21 billion in the period, exceeding Street forecasts. Seven analysts surveyed by Zacks expected $1.11 billion.
Jazz expects full-year revenue in the range of $4.6 billion to $4.75 billion.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/JAZZ
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
